CD40L - A Multipotent Molecule for Tumor Therapy
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
7
Page:
23-28
Author(s):
Angelica Loskog and Thomas H. Totterman
Evaluation of Polygonum bistorta for Anticancer Potential Using Selected Cancer Cell Lines
Journal:
Medicinal Chemistry
Volume:
3
Page:
121-126
Author(s):
Karuppiah Pillai Manoharan, Daiwen Yang, Annie Hsu and Benny Tan Kwong Huat
CD26/Dipeptidyl Peptidase IV as a Novel Therapeutic Target for Cancer and Immune Disorders
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
7
Page:
253-273
Author(s):
Michael A. Thompson, Kei Ohnuma, Masako Abe, Chikao Morimoto and Nam H. Dang
Effects of Polymorphisms of the CYP450 Enzyme Genes on Estrogen Status and the Risk for Osteoporosis
Journal:
Current Pharmacogenomics
Volume:
5
Page:
1-10
Author(s):
Nicola Napoli and Reina Armamento-Villareal
Gold Nanoparticle Based Systems in Genetics
Journal:
Current Pharmacogenomics
Volume:
5
Page:
39-47
Author(s):
Jorge Francisco Gaspar, Pedro Viana Baptista and Jose Rueff
Genetic Polymorphisms and Haplotypes of Major Drug Metabolizing Enzymes in East Asians and Their Comparison with Other Ethnic Populations
Journal:
Current Pharmacogenomics
Volume:
5
Page:
49-78
Author(s):
Y. Saito, K. Maekawa, S. Ozawa and J. Sawada
Lysophospholipase D/Autotaxin in Lysophospholipid Biology
Journal:
Current Enzyme Inhibition
Volume:
3
Page:
13-17
Author(s):
Dong-Soon Im
Silybin and Silymarin - New and Emerging Applications in Medicine
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
315-338
Author(s):
Radek Gazak, Daniela Walterova and Vladimir Kren
β-Carboline Alkaloids: Biochemical and Pharmacological Functions
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
479-500
Author(s):
Rihui Cao, Wenlie Peng, Zihou Wang and Anlong Xu
Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
Journal:
Current Drug Targets
Volume:
8
Page:
217-235
Author(s):
M. A. Morgan, A. Ganser and C. W. M. Reuter